Skip to main content
. 2023 Oct 9;2(11):1078–1094. doi: 10.1038/s44161-023-00346-3

Extended Data Table 1.

Clinical characteristics of 241 individuals with autosomal recessive CM caused by biallelic variants in 18 validated genes

All (n=241) DCM (n=122) HCM (n=53)
Cardiomyopathy DCM 122 (50.6%)
HCM 53 (22.0%)
Other 66 (27.4%)
Sex assigned at birth Female 109 (45.2%) 52 (42.6%) 21 (39.6%)
Male 128 (53.1%) 66 (54.1%) 32 (60.4%)
Unknown 4 (1.7%) 4 (3.3%) 0 (0%)
Age of onset (years) Mean (SD) 12.2 (14.9) 8.51 (11.4) 25.4 (16.4)
Median [Min, Max] 4.00 [0, 69.0] 3.00 [0, 56.0] 24.0 [0, 69.0]
Unknown 22 (9.1%) 15 (12.3%) 3 (5.7%)
Age of outcome (years) Mean (SD) 17.7 (19.0) 13.9 (15.8) 37.9 (17.7)
Median [Min, Max] 11.5 [0, 78.0] 7.00 [0, 59.0] 37.5 [0.33, 78.0]
Unknown 29 (12.0%) 13 (10.7%) 5 (9.4%)
Outcomes Alive 98 (40.7%) 37 (30.3%) 42 (79.2%)
Deceased 100 (41.5%) 54 (44.3%) 4 (7.5%)
Heart transplant 26 (10.8%) 20 (16.4%) 3 (5.7%)
LVAD 6 (2.5%) 6 (4.9%) 0 (0%)
Unknown 11 (4.6%) 5 (4.1%) 4 (7.5%)
Variant zygosity Compound heterozygous 64 (26.6%) 32 (26.2%) 6 (11.3%)
Double heterozygous 12 (5.0%) 5 (4.1%) 7 (13.2%)
Homozygous 165 (68.5%) 85 (69.7%) 40 (75.5%)
Variant class Biallelic truncating 112 (46.5%) 74 (60.7%) 24 (45.3%)
Biallelic non-truncating 104 (43.2%) 35 (28.7%) 21 (39.6%)
Biallelic mixed 25 (10.4%) 13 (10.7%) 8 (15.1%)

DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; LVAD. Left ventricular assist device; SD, standard deviation.